LOWELL, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to ...

Rapid Micro Biosystems and Merck KGaA have signed a five-year global distribution agreement for Growth Direct systems and consumables. Rapid Micro Biosystems, Inc. has entered a five-year global ...

The new Rapid Sterility application includes a novel, proprietary test kit that has been developed for use with the Company’s fully automated Growth Direct system and delivers time to organism ...

Robert Spignesi, CEO, opened by highlighting third quarter revenue of $7.8 million, which was above the midpoint of guidance and marked the twelfth consecutive quarter meeting or beating revenue ...

Reports third quarter 2025 total revenue of $7.8 million, representing 3% growth compared to the third quarter of 2024. Third quarter 2025 recurring revenue, which includes consumables and annual ...